Stay updated on Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag was updated from v3.5.2 to v3.5.3. This reflects a minor metadata update to the ClinicalTrials.gov page without changing the study content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check55 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.4.2 was added and the funding/operating-status notice was removed. The core study content and page structure remain unchanged.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded a government funding notice indicating the site may not be up to date and that the NIH Clinical Center is open, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.